Figure 3
Figure 3. Reduced RANKL/OPG ratio and PINP levels in ADA-deficient mice. (A) Murine serum RANKL (ng/mL) in ADA+/+ (n = 22) and ADA−/− (n = 18), Rag2γc+/+ (n = 10), and Rag2γc−/− (n = 14) mice. (B) Murine OPG (ng/mL). (C) Murine RANKL/OPG ratio (AU). ***P < .001. **P = .001-.005. *P = .005-.05. N.S. indicates not significant. (D) In vivo bone formation rate as assessed by PINP levels are significantly lower in ADA−/− mice compared with wild-type controls. Serum PINP levels (ng/mL), ADA+/+ (n = 9), ADA−/− (n = 9), Rag2γc+/+ (n = 15), and Rag2γc−/− (n = 13).

Reduced RANKL/OPG ratio and PINP levels in ADA-deficient mice. (A) Murine serum RANKL (ng/mL) in ADA+/+ (n = 22) and ADA−/− (n = 18), Rag2γc+/+ (n = 10), and Rag2γc−/− (n = 14) mice. (B) Murine OPG (ng/mL). (C) Murine RANKL/OPG ratio (AU). ***P < .001. **P = .001-.005. *P = .005-.05. N.S. indicates not significant. (D) In vivo bone formation rate as assessed by PINP levels are significantly lower in ADA−/− mice compared with wild-type controls. Serum PINP levels (ng/mL), ADA+/+ (n = 9), ADA−/− (n = 9), Rag2γc+/+ (n = 15), and Rag2γc−/− (n = 13).

Close Modal

or Create an Account

Close Modal
Close Modal